J. Salmanton-García Et Al. , "Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry," eClinicalMedicine , vol.58, 2023
Salmanton-García, J. Et Al. 2023. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. eClinicalMedicine , vol.58 .
Salmanton-García, J., Marchesi, F., Gomes da Silva, M., Farina, F., Dávila-Valls, J., Bilgin, Y. M., ... Glenthøj, A.(2023). Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry. eClinicalMedicine , vol.58.
Salmanton-García, Jon Et Al. "Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry," eClinicalMedicine , vol.58, 2023
Salmanton-García, Jon Et Al. "Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry." eClinicalMedicine , vol.58, 2023
Salmanton-García, J. Et Al. (2023) . "Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry." eClinicalMedicine , vol.58.
@article{article, author={Jon Salmanton-García Et Al. }, title={Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry}, journal={eClinicalMedicine}, year=2023}